Increasing rates of NCCN high and very high-risk prostate cancer versus number of prostate biopsy cores
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: The prostate 81.2021, 12, S. 874-881. doi:10.1002/pros.24184, ISSN 1097-0045
- Ereignis
-
Veröffentlichung
- (wo)
-
Frankfurt am Main
- (wer)
-
Universitätsbibliothek Johann Christian Senckenberg
- (wann)
-
2021
- Urheber
-
Wenzel, Mike
Würnschimmel, Christoph
Ruvolo, Claudia C.
Nocera, Luigi
Tian, Zhe
Saad, Fred
Briganti, Alberto
Tilki, Derya
Graefen, Markus
Kluth, Luis
Mandel, Philipp
Chun, Felix
Karakiewicz, Pierre I.
- URN
-
urn:nbn:de:hebis:30:3-639269
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:28 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Wenzel, Mike
- Würnschimmel, Christoph
- Ruvolo, Claudia C.
- Nocera, Luigi
- Tian, Zhe
- Saad, Fred
- Briganti, Alberto
- Tilki, Derya
- Graefen, Markus
- Kluth, Luis
- Mandel, Philipp
- Chun, Felix
- Karakiewicz, Pierre I.
- Universitätsbibliothek Johann Christian Senckenberg
Entstanden
- 2021
Ähnliche Objekte (12)
Prostate cancer: active surveillance, diagnostic modalities and biopsy in the management of prostate cancer
Hüftkappenendoprothesen : Einzelstrukturanalyse und Dokumentation alter Wagnerkappen als Basis für die Interpretation des modernen Hüftkopfoberflächenersatzes
Complication rates after trus guided transrectal systematic and mri-targeted prostate biopsies in a high-risk region for antibiotic resistances
Cancer-specific survival after radical prostatectomy versus external beam radiotherapy in high-risk and very high-risk African American prostate cancer patients
Impact of "time-from-biopsy-to-prostatectomy" on adverse oncological results in patients with intermediate and high-risk prostate cancer
Non-organ confined stage and upgrading rates in exclusive PSA high-risk prostate cancer patients
Editorial: Sequelae of prostate cancer therapy: Avoidance strategies and management options
Concordance between preoperative mpMRI and pathological stage and its influence on nerve-sparing surgery in patients with high-risk prostate cancer
Holmium laser enucleation of the prostate: efficacy, safety and preoperative management in patients presenting with anticoagulation therapy
Holmium laser enucleation of the prostate: efficacy, safety and preoperative management in patients presenting with anticoagulation therapy
Diagnosis of clinically significant prostate cancer diagnosis without histological proof in the prostate-specific membrane antigen era: the jury is still out
Overall survival and adverse events after treatment with darolutamide vs. apalutamide vs. enzalutamide for high-risk non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis
Prostate cancer: active surveillance, diagnostic modalities and biopsy in the management of prostate cancer
Hüftkappenendoprothesen : Einzelstrukturanalyse und Dokumentation alter Wagnerkappen als Basis für die Interpretation des modernen Hüftkopfoberflächenersatzes
Complication rates after trus guided transrectal systematic and mri-targeted prostate biopsies in a high-risk region for antibiotic resistances
Cancer-specific survival after radical prostatectomy versus external beam radiotherapy in high-risk and very high-risk African American prostate cancer patients
Impact of "time-from-biopsy-to-prostatectomy" on adverse oncological results in patients with intermediate and high-risk prostate cancer
Non-organ confined stage and upgrading rates in exclusive PSA high-risk prostate cancer patients
Editorial: Sequelae of prostate cancer therapy: Avoidance strategies and management options
Concordance between preoperative mpMRI and pathological stage and its influence on nerve-sparing surgery in patients with high-risk prostate cancer
Holmium laser enucleation of the prostate: efficacy, safety and preoperative management in patients presenting with anticoagulation therapy
Holmium laser enucleation of the prostate: efficacy, safety and preoperative management in patients presenting with anticoagulation therapy
Diagnosis of clinically significant prostate cancer diagnosis without histological proof in the prostate-specific membrane antigen era: the jury is still out
Overall survival and adverse events after treatment with darolutamide vs. apalutamide vs. enzalutamide for high-risk non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis
Prostate cancer: active surveillance, diagnostic modalities and biopsy in the management of prostate cancer
Hüftkappenendoprothesen : Einzelstrukturanalyse und Dokumentation alter Wagnerkappen als Basis für die Interpretation des modernen Hüftkopfoberflächenersatzes
Complication rates after trus guided transrectal systematic and mri-targeted prostate biopsies in a high-risk region for antibiotic resistances
Cancer-specific survival after radical prostatectomy versus external beam radiotherapy in high-risk and very high-risk African American prostate cancer patients
Impact of "time-from-biopsy-to-prostatectomy" on adverse oncological results in patients with intermediate and high-risk prostate cancer
Non-organ confined stage and upgrading rates in exclusive PSA high-risk prostate cancer patients
Editorial: Sequelae of prostate cancer therapy: Avoidance strategies and management options
Concordance between preoperative mpMRI and pathological stage and its influence on nerve-sparing surgery in patients with high-risk prostate cancer
Holmium laser enucleation of the prostate: efficacy, safety and preoperative management in patients presenting with anticoagulation therapy
Holmium laser enucleation of the prostate: efficacy, safety and preoperative management in patients presenting with anticoagulation therapy
Diagnosis of clinically significant prostate cancer diagnosis without histological proof in the prostate-specific membrane antigen era: the jury is still out